Imagine if your immune system had superhero powers ♂️! A new study found that a cancer drug called Opdivo, when combined with chemotherapy, not only helped patients with bladder cancer live longer, but also kept the disease at bay. The drug successfully achieved its two main goals in a late-stage trial. It’s like having a trusty sidekick by your side, fighting off the cancer cells and preventing them from spreading! Opdivo, developed by Bristol Myers Squibb Co, is a type of immunotherapy that helps activate your body’s natural defenses to attack cancer. By working alongside chemotherapy, it strengthens the immune system’s response and gives patients a better chance at survival . This groundbreaking research shows the potential of combining different treatment approaches to tackle tough cancers like bladder cancer. To learn more about this exciting study and how it could impact cancer treatment, check out the full article!
